tiprankstipranks
Trending News
More News >
LifeMD (LFMD)
NASDAQ:LFMD
US Market
Advertisement

LifeMD (LFMD) Earnings Dates, Call Summary & Reports

Compare
708 Followers

Earnings Data

Report Date
Mar 16, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.06
Last Year’s EPS
-0.02
Same Quarter Last Year
Based on 7 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 17, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call highlighted significant strategic advancements and growth potential, particularly in telehealth and partnerships with major pharmaceutical companies. However, challenges in the weight management category and a decline in gross margin were notable concerns.
Company Guidance
During the LifeMD third-quarter earnings call, the company provided guidance for strong growth in 2026, driven by several strategic initiatives. The company reported a year-over-year increase in telehealth revenue by 18% and a 30% rise in adjusted EBITDA. For the fourth quarter, LifeMD anticipates revenue of $45-$46 million and adjusted EBITDA of $3-$4 million. The full year 2025 guidance includes revenue between $192-$193 million and adjusted EBITDA of $13.5-$14.5 million, representing a 24% and 254% increase, respectively, over 2024. Key growth areas highlighted include the expansion of women's and behavioral health offerings, the launch of the LifeMD+ membership, and the development of a more integrated platform and marketplace. The company expects these initiatives, along with strategic partnerships with Novo Nordisk and Eli Lilly for weight management treatments, to significantly enhance patient engagement and retention, ultimately positioning LifeMD for robust growth in the coming year.
Telehealth Revenue Growth
Telehealth revenue increased by 18% year-over-year to $47.3 million with telehealth adjusted EBITDA growing 30%.
RexMD Subscriber Growth
RexMD business added approximately 10,000 net new subscribers, signaling a return to growth.
Regulatory Approval for Pharmacy
LifeMD secured regulatory approval for its nonsterile 503-A compounding pharmacy, which will expand the ability to produce personalized medications at scale.
Partnerships with Pharmaceutical Companies
Collaborations with Novo Nordisk and Eli Lilly to offer branded weight management therapies at reduced prices.
Strong Balance Sheet
LifeMD reported the strongest balance sheet and liquidity position in the company's history, with $23.8 million in cash and no debt.

LifeMD (LFMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LFMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 16, 2026
2025 (Q4)
-0.06 / -
-0.02
Nov 17, 2025
2025 (Q3)
-0.02 / -0.10
-0.1428.57% (+0.04)
Aug 05, 2025
2025 (Q2)
>-0.01 / -0.06
-0.1968.42% (+0.13)
May 06, 2025
2025 (Q1)
-0.05 / 0.01
-0.19105.26% (+0.20)
Mar 10, 2025
2024 (Q4)
-0.05 / -0.02
-0.1283.33% (+0.10)
Nov 07, 2024
2024 (Q3)
-0.12 / -0.14
-0.230.00% (+0.06)
Aug 07, 2024
2024 (Q2)
-0.14 / -0.19
0.05-480.00% (-0.24)
May 08, 2024
2024 (Q1)
-0.15 / -0.19
0.06-416.67% (-0.25)
Mar 11, 2024
2023 (Q4)
-0.14 / -0.12
-0.470.00% (+0.28)
Nov 08, 2023
2023 (Q3)
-0.09 / -0.20
-0.03-566.67% (-0.17)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

LFMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 17, 2025
$4.73$4.09-13.53%
Aug 05, 2025
$11.84$6.53-44.85%
May 06, 2025
$7.76$8.01+3.22%
Mar 10, 2025
$4.27$5.58+30.68%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does LifeMD (LFMD) report earnings?
LifeMD (LFMD) is schdueled to report earning on Mar 16, 2026, Before Open (Confirmed).
    What is LifeMD (LFMD) earnings time?
    LifeMD (LFMD) earnings time is at Mar 16, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LFMD EPS forecast?
          LFMD EPS forecast for the fiscal quarter 2025 (Q4) is -0.06.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis